Back to Results
First PageMeta Content
ALS Therapy Development Institute / Amyotrophic lateral sclerosis / ALS Association / Biology / Biomarker / Motor neurone disease / James Heywood / Prize4Life / Rare diseases / Health / Medicine


Academic and Pharmaceutical Leaders Meet at the ALS Therapy Development Institute to Discuss Biomarkers in ALS
Add to Reading List

Document Date: 2014-05-19 07:40:32

Open Document

File Size: 366,20 KB

Share Result on Facebook

City

CAMBRIDGE / /

Company

Astra Zeneca / Pfizer / The ALS Association / Iron Horse Diagnostics Inc. / Northeast ALS Consortium / Novartis / Voyager Therapeutics / Weiner Laboratory / Biogen Idec / ALS TDI / Genentech / Bristol-Myers Squibb / /

Country

Switzerland / /

Event

FDA Phase / /

Facility

Massachusetts General Hospital / University of Massachusetts Medical School / National Institute of Neurological Disorders / Barrow Neurological Institute / About ALS Therapy Development Institute / ALS Therapy Development Institute / SUNY Upstate Medical University / /

IndustryTerm

biotechnology / pharmaceutical / /

MedicalCondition

MND / disease / ALS / /

Organization

National Institute of Neurological Disorders and Stroke / ALS Association / SUNY Upstate Medical University / Michael J. Fox Foundation for Parkinson / Barrow Neurological Institute / ALS Therapy Development Institute / Massachusetts General Hospital / University of Massachusetts Medical School / /

Person

Lucie Bruijn / Steve Perrin / /

Position

Chief Scientist / CEO and Chief Scientific Officer / /

Product

ALS TDI / /

TVShow

Parkinson / /

Technology

biotechnology / drug development / /

URL

www.als.net / /

SocialTag